Vanguard Group
TPST icon

Vanguard Group’s Tempest Therapeutics TPST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$915K Sell
134,608
-163,269
-55% -$1.11M ﹤0.01% 3768
2025
Q1
$220K Buy
297,877
+121,684
+69% +$89.8K ﹤0.01% 4055
2024
Q4
$147K Hold
176,193
﹤0.01% 4135
2024
Q3
$247K Hold
176,193
﹤0.01% 4101
2024
Q2
$386K Hold
176,193
﹤0.01% 4063
2024
Q1
$689K Hold
176,193
﹤0.01% 3931
2023
Q4
$775K Sell
176,193
-36,120
-17% -$159K ﹤0.01% 3905
2023
Q3
$64.7K Sell
212,313
-97,527
-31% -$29.7K ﹤0.01% 4386
2023
Q2
$393K Buy
309,840
+59,889
+24% +$76.1K ﹤0.01% 4183
2023
Q1
$580K Buy
249,951
+8,988
+4% +$20.9K ﹤0.01% 4082
2022
Q4
$277K Buy
240,963
+201
+0.1% +$231 ﹤0.01% 4241
2022
Q3
$419K Sell
240,762
-7,512
-3% -$13.1K ﹤0.01% 4261
2022
Q2
$534K Sell
248,274
-814
-0.3% -$1.75K ﹤0.01% 4277
2022
Q1
$842K Sell
249,088
-42,220
-14% -$143K ﹤0.01% 4263
2021
Q4
$1.54M Sell
291,308
-67,858
-19% -$358K ﹤0.01% 4132
2021
Q3
$5.2M Buy
359,166
+298,016
+487% +$4.31M ﹤0.01% 3632
2021
Q2
$683K Sell
61,150
-301,776
-83% -$3.37M ﹤0.01% 4217
2021
Q1
$436K Buy
362,926
+43,209
+14% +$51.9K ﹤0.01% 4154
2020
Q4
$684K Sell
319,717
-83
-0% -$178 ﹤0.01% 3908
2020
Q3
$521K Sell
319,800
-235,871
-42% -$384K ﹤0.01% 3804
2020
Q2
$978K Sell
555,671
-60,765
-10% -$107K ﹤0.01% 3620
2020
Q1
$3.26M Buy
616,436
+13,242
+2% +$69.9K ﹤0.01% 3155
2019
Q4
$4.07M Buy
603,194
+203,865
+51% +$1.37M ﹤0.01% 3235
2019
Q3
$2.84M Buy
399,329
+68,044
+21% +$484K ﹤0.01% 3332
2019
Q2
$3.83M Buy
331,285
+126,994
+62% +$1.47M ﹤0.01% 3261
2019
Q1
$3.06M Buy
204,291
+152,874
+297% +$2.29M ﹤0.01% 3315
2018
Q4
$409K Sell
51,417
-1,291,960
-96% -$10.3M ﹤0.01% 3771
2018
Q3
$980K Buy
1,343,377
+30,445
+2% +$22.2K ﹤0.01% 3728
2018
Q2
$1.19M Sell
1,312,932
-2,746
-0.2% -$2.49K ﹤0.01% 3641
2018
Q1
$1.07M Buy
1,315,678
+13,532
+1% +$11K ﹤0.01% 3635
2017
Q4
$1.82M Sell
1,302,146
-226,295
-15% -$317K ﹤0.01% 3452
2017
Q3
$2.17M Buy
1,528,441
+18,113
+1% +$25.7K ﹤0.01% 3372
2017
Q2
$2.36M Sell
1,510,328
-143,064
-9% -$223K ﹤0.01% 3333
2017
Q1
$3.09M Buy
1,653,392
+344,337
+26% +$644K ﹤0.01% 3236
2016
Q4
$2M Buy
1,309,055
+97,098
+8% +$148K ﹤0.01% 3364
2016
Q3
$8.68M Buy
1,211,957
+78,440
+7% +$562K ﹤0.01% 2752
2016
Q2
$5.91M Buy
1,133,517
+305,783
+37% +$1.59M ﹤0.01% 2896
2016
Q1
$7.86M Buy
827,734
+26,810
+3% +$254K ﹤0.01% 2738
2015
Q4
$7.83M Buy
800,924
+36,703
+5% +$359K ﹤0.01% 2766
2015
Q3
$6.49M Buy
764,221
+26,476
+4% +$225K ﹤0.01% 2844
2015
Q2
$21.3M Buy
737,745
+92,693
+14% +$2.68M ﹤0.01% 2325
2015
Q1
$22.4M Buy
645,052
+231,206
+56% +$8.03M ﹤0.01% 2277
2014
Q4
$18.3M Buy
413,846
+122,826
+42% +$5.43M ﹤0.01% 2265
2014
Q3
$4.83M Buy
291,020
+23,147
+9% +$384K ﹤0.01% 2841
2014
Q2
$2.46M Buy
267,873
+35,501
+15% +$325K ﹤0.01% 3175
2014
Q1
$2.08M Buy
232,372
+106,873
+85% +$955K ﹤0.01% 3207
2013
Q4
$1.15M Buy
125,499
+21,363
+21% +$195K ﹤0.01% 3378
2013
Q3
$1.03M Sell
104,136
-476
-0.5% -$4.72K ﹤0.01% 3358
2013
Q2
$1.44M Buy
+104,612
New +$1.44M ﹤0.01% 3186